Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review
<b>Background</b>: Giant cell tumor of bone (GCTB) is a locally aggressive tumor. It accounts for only 5% of all bony tumors. Early diagnosis, and follow-up for recurrence is often difficult due to a lack of biogenetic markers. Giant cells are multinucleated epithelioid cells derived from macrophage...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2024-12-01
|
| Saila: | Diagnostics |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2075-4418/15/1/39 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
